- Home
- SPTN vs HUMA Comparison
SPTN vs HUMA Comparison
Compare SPTN & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPTN
- HUMA
- Stock Information
- Founded
- SPTN 1917
- HUMA 2004
- Country
- SPTN United States
- HUMA United States
- Employees
- SPTN N/A
- HUMA N/A
- Industry
- SPTN Food Distributors
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- SPTN Consumer Discretionary
- HUMA Health Care
- Exchange
- SPTN Nasdaq
- HUMA Nasdaq
- Market Cap
- SPTN 618.4M
- HUMA 577.7M
- IPO Year
- SPTN N/A
- HUMA N/A
- Fundamental
- Price
- SPTN $17.49
- HUMA $4.39
- Analyst Decision
- SPTN Hold
- HUMA Strong Buy
- Analyst Count
- SPTN 1
- HUMA 7
- Target Price
- SPTN $20.00
- HUMA $13.43
- AVG Volume (30 Days)
- SPTN 328.9K
- HUMA 8.2M
- Earning Date
- SPTN 02-13-2025
- HUMA 11-08-2024
- Dividend Yield
- SPTN 4.96%
- HUMA N/A
- EPS Growth
- SPTN 9.92
- HUMA N/A
- EPS
- SPTN 1.33
- HUMA N/A
- Revenue
- SPTN $9,532,883,000.00
- HUMA N/A
- Revenue This Year
- SPTN N/A
- HUMA N/A
- Revenue Next Year
- SPTN $2.15
- HUMA $5,584.53
- P/E Ratio
- SPTN $13.16
- HUMA N/A
- Revenue Growth
- SPTN N/A
- HUMA N/A
- 52 Week Low
- SPTN $17.30
- HUMA $2.48
- 52 Week High
- SPTN $23.00
- HUMA $9.97
- Technical
- Relative Strength Index (RSI)
- SPTN 30.01
- HUMA 44.65
- Support Level
- SPTN $17.96
- HUMA $4.86
- Resistance Level
- SPTN $18.65
- HUMA $5.33
- Average True Range (ATR)
- SPTN 0.49
- HUMA 0.59
- MACD
- SPTN -0.08
- HUMA -0.02
- Stochastic Oscillator
- SPTN 8.35
- HUMA 8.81
About SPTN SpartanNash Company
SpartanNash Co is a food solutions company that delivers the ingredients. Its principal business activities include, distributing grocery products to a diverse group of independent and chain retailers, its corporate-owned retail stores, and U.S. military commissaries and exchanges; as well as operating a fresh produce distribution network and the Our Family private label brand. The company operates in two segments: Retail and Wholesale. Majority of the revenue is earned from its Wholesale segment which uses a multi-channel sales approach to distribute national brand and private brand products to independent retailers, national accounts, food service distributors, e-commerce providers, and the Company's corporate owned retail stores.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.